Vitalibis, Inc.

VCBD

US92849U1051

Pharmaceuticals

Delayed OTC Markets Other stock markets 14:58:00 2024-07-11 EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	-50.00%

2021	Vitalibis, Inc. Bankruptcy Case Dismissed	CI
2021	Motion for Case Dismissal Filed for Vitalibis, Inc.	CI

Sheng Ying Entertainment Corp. will Change its Name to Vitalibis, Inc

February 08, 2018 at 12:00 am

Effective February 08, 2018, Sheng Ying Entertainment Corp. will change its name to Vitalibis, Inc.

Latest news about Vitalibis, Inc.

Vitalibis, Inc. Bankruptcy Case Dismissed	21-09-02	CI
Motion for Case Dismissal Filed for Vitalibis, Inc.	21-08-02	CI
Disclosure Statement Conditionally Approved for Vitalibis, Inc.	20-11-18	CI
Reorganization Plan and Disclosure Statement Filed by Vitalibis, Inc.	20-11-18	CI
Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-17	CI
Vitalibis, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Vitalibis, Inc. Filed for Bankruptcy	20-06-15	CI
Vitalibis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-15	CI
Vitalibis, Inc. Alliance with Bruce Lee Beverage by Offering Actual Being™ Focus Adaptogen + Superfood Herbal Supplement	20-04-01	CI
Vitalibis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-13	CI
Vitalibis, Inc. Auditor Raises 'Going Concern' Doubt	20-03-12	CI
Vitalibis, Inc. Launches CBD+ Skincare Product Line	20-01-28	CI
Vitalibis and OakLeaf Wellness + Health Announce National Alliance to Distribute Full-Spectrum CBD Wellness Products	19-12-12	CI
Vitalibis, Inc. and Stylevate Completes Technology Integration Using Proprietary Peer-to-Peer Engagement SaaS Platform In Fashion Industry	19-11-19	CI
Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-08	CI
Vitalibis, Inc. Announces Business Alliance with Natural Recovery Greens	19-10-17	CI
Vitalibis and Living Beyond Breast Cancer Form Business Alliance Dedicated to Providing Education, Programs and Services for Those Impacted by Breast Cancer	19-10-10	CI
Vitalibis, Inc. Announces Appointment of Dave Harper to the Advisory Board	19-09-25	CI
Vitalibis, Inc. Announces Premium Water Soluble Hemp Powder Supply Agreement with UbU Beverages	19-09-17	CI
Vitalibis, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-09	CI
Vitalibis Launches Signature AB900 Hemp Oil with Naturally Occurring CBD in Collaboration with the Bruce Lee Family	19-06-26	CI
Vitalibis, Inc. Appoints Steven Zodkoy as Founding Member of Scientific Advisory Board	19-05-17	CI
Vitalibis, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019	19-05-13	CI
Vitalibis Launches New Signature 600 Premium CBD Hemp Oil	19-04-15	CI
Vitalibis, Inc. Appoints Dusty Baker to Advisory Board	19-04-02	CI

Vitalibis, Inc. is a socially conscious brand focused on people, products and the planet. The Company is a technology-based formulator of premium, full spectrum Phyto cannabinoid rich hemp products with naturally occurring cannabidiol, along with safe personal care and nutritional products. The Companyâs Ambassador program combines the elements of social selling, ecommerce and affiliate marketing into one program empowering its people and social mission driven ecosystem.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VITALIBIS, INC.	-50.00%	34.59K
ELI LILLY AND COMPANY	+62.88%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.95%	359B
MERCK & CO., INC.	+15.91%	325B
ABBVIE INC.	+8.88%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.56%	177B
PFIZER, INC.	+1.89%	165B

Other Pharmaceuticals

Vitalibis, Inc.

Equities

VCBD

US92849U1051

Pharmaceuticals

Sheng Ying Entertainment Corp. will Change its Name to Vitalibis, Inc

Latest news about Vitalibis, Inc.

Chart Vitalibis, Inc.

Company Profile

Sector Other Pharmaceuticals